123 related articles for article (PubMed ID: 22264592)
1. Findings in the pulmonary vascular bed in the remote phase after Kawasaki disease.
Sugimoto M; Ishido H; Seki M; Masutani S; Tamai A; Senzaki H
Am J Cardiol; 2012 Apr; 109(8):1219-22. PubMed ID: 22264592
[TBL] [Abstract][Full Text] [Related]
2. Arterial hemodynamics in patients after Kawasaki disease.
Senzaki H; Chen CH; Ishido H; Masutani S; Matsunaga T; Taketazu M; Kobayashi T; Sasaki N; Kyo S; Yokote Y
Circulation; 2005 Apr; 111(16):2119-25. PubMed ID: 15851619
[TBL] [Abstract][Full Text] [Related]
3. Arterial stiffness in patients after Kawasaki disease without coronary artery involvement: Assessment by performing brachial ankle pulse wave velocity and cardio-ankle vascular index.
Nakagawa R; Kuwata S; Kurishima C; Saiki H; Iwamoto Y; Sugimoto M; Ishido H; Masutani S; Senzaki H
J Cardiol; 2015 Aug; 66(2):130-4. PubMed ID: 25458191
[TBL] [Abstract][Full Text] [Related]
4. Echo-Doppler assessment of arterial stiffness in pediatric patients with Kawasaki disease.
AlHuzaimi A; Al Mashham Y; Potts JE; De Souza AM; Sandor GG
J Am Soc Echocardiogr; 2013 Sep; 26(9):1084-9. PubMed ID: 23800509
[TBL] [Abstract][Full Text] [Related]
5. The biophysical properties of the aorta are altered following Kawasaki disease.
Vaujois L; Dallaire F; Maurice RL; Fournier A; Houde C; Thérien J; Cartwright D; Dahdah N
J Am Soc Echocardiogr; 2013 Dec; 26(12):1388-96. PubMed ID: 24094561
[TBL] [Abstract][Full Text] [Related]
6. Circulating endothelial glycocalyx components as a predictive marker of coronary artery lesions in Kawasaki disease.
Ohnishi Y; Yasudo H; Suzuki Y; Furuta T; Matsuguma C; Azuma Y; Miyake A; Okada S; Ichihara K; Ohga S; Hasegawa S
Int J Cardiol; 2019 Oct; 292():236-240. PubMed ID: 31200965
[TBL] [Abstract][Full Text] [Related]
7. Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease.
Cheung YF; Wong SJ; Ho MH
Arch Dis Child; 2007 Jan; 92(1):43-7. PubMed ID: 16820386
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 in patients with Kawasaki disease: diagnostic value for the prediction of coronary artery lesion and implication for a new mode of therapy.
Senzaki H; Kobayashi T; Nagasaka H; Nakano H; Kyo S; Yokote Y; Sasakid N
Pediatr Res; 2003 Jun; 53(6):983-8. PubMed ID: 12621103
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.
Weng KP; Hsieh KS; Huang SH; Ou SF; Ma CY; Ho TY; Lai CR; Ger LP
Kaohsiung J Med Sci; 2012 Jan; 28(1):23-9. PubMed ID: 22226058
[TBL] [Abstract][Full Text] [Related]
10. Ascending Aorta Elastography After Kawasaki Disease Compared to Systemic Hypertension.
Nandlall I; Maurice RL; Fournier A; Merouani A; Dahdah N
Pediatr Cardiol; 2015 Oct; 36(7):1417-22. PubMed ID: 25921428
[TBL] [Abstract][Full Text] [Related]
11. Association between adropin and coronary artery lesions in children with Kawasaki disease.
Yang M; Pei Q; Zhang J; Weng H; Jing F; Yi Q
Eur J Pediatr; 2021 Jul; 180(7):2253-2259. PubMed ID: 33712900
[TBL] [Abstract][Full Text] [Related]
12. Genetic analysis of MMP gene polymorphisms in patients with Kawasaki disease.
Ikeda K; Ihara K; Yamaguchi K; Muneuchi J; Ohno T; Mizuno Y; Hara T
Pediatr Res; 2008 Feb; 63(2):182-5. PubMed ID: 18091353
[TBL] [Abstract][Full Text] [Related]
13. ITPKC gene SNP rs28493229 and Kawasaki disease in Taiwanese children.
Chi H; Huang FY; Chen MR; Chiu NC; Lee HC; Lin SP; Chen WF; Lin CL; Chan HW; Liu HF; Huang LM; Lee YJ
Hum Mol Genet; 2010 Mar; 19(6):1147-51. PubMed ID: 20045869
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
Honkanen VE; McCrindle BW; Laxer RM; Feldman BM; Schneider R; Silverman ED
Pediatr Cardiol; 2003; 24(2):122-6. PubMed ID: 12457252
[TBL] [Abstract][Full Text] [Related]
15. Vascular health in Kawasaki disease.
Selamet Tierney ES; Gal D; Gauvreau K; Baker AL; Trevey S; O'Neill SR; Jaff MR; de Ferranti S; Fulton DR; Colan SD; Newburger JW
J Am Coll Cardiol; 2013 Sep; 62(12):1114-1121. PubMed ID: 23835006
[TBL] [Abstract][Full Text] [Related]
16. S100A12 on circulating endothelial cells surface in children with Kawasaki disease.
Fu S; Gong F; Xie C; Zhu W; Wang W; Shen H; Tang Y
Pediatr Res; 2010 Aug; 68(2):165-8. PubMed ID: 20461025
[TBL] [Abstract][Full Text] [Related]
17. [The study of vascular lesion using ultrasound in children with a history of Kawasaki disease].
Liu XQ; Huang GY; Liang XC; Tao ZY; Chen WD; Lin QS
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2117-20. PubMed ID: 17988531
[TBL] [Abstract][Full Text] [Related]
18. State-of-the-art acute phase management of Kawasaki disease after 2017 scientific statement from the American Heart Association.
Liu YC; Lin MT; Wang JK; Wu MH
Pediatr Neonatol; 2018 Dec; 59(6):543-552. PubMed ID: 29706362
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y
Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
[TBL] [Abstract][Full Text] [Related]
20. Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease.
Cheung YF; Ho MH; Tam SC; Yung TC
Heart; 2004 Nov; 90(11):1281-5. PubMed ID: 15486121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
